Age and aging in blood disorders: multiple myeloma

Yazar: Zweegman, Sonja, Palumbo, Antonio, Bringhen, Sara, Sonneveld, Pieter
Baskı/Yayın Bilgisi 2014

Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

Yazar: Engelhardt, Monika, Yong, Kwee, Bringhen, Sara, Wäsch, Ralph
Yayımlandı Haematologica (2019)

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

Yazar: Mattia D’Agostino, Salvatore Innorcia, Mario Boccadoro, Sara Bringhen
Baskı/Yayın Bilgisi 2020-11-01

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

Yazar: D’Agostino, Mattia, Innorcia, Salvatore, Boccadoro, Mario, Bringhen, Sara
Yayımlandı Int J Mol Sci (2020)

Emerging drugs and combinations to treat multiple myeloma

Yazar: Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario
Yayımlandı Oncotarget (2017)

Approach to the Older Adult With Multiple Myeloma

Yazar: Mina, Roberto, Bringhen, Sara, Wildes, Tanya M., Zweegman, Sonja, Rosko, Ashley E.
Yayımlandı Am Soc Clin Oncol Educ Book (2019)

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

Yazar: Bonello, Francesca, Grasso, Mariella, D’Agostino, Mattia, Celeghini, Ivana, Castellino, Alessia, Boccadoro, Mario, Bringhen, Sara
Yayımlandı Pharmaceuticals (Basel) (2020)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

Yazar: Mateos, María-Victoria, Bladé, Joan, Bringhen, Sara, Ocio, Enrique M, Efebera, Yvonne, Pour, Luděk, Gay, Francesca, Sonneveld, Pieter, Gullbo, Joachim, Richardson, Paul G.
Yayımlandı J Clin Med (2020)

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy

Yazar: Bruno, Giulia, Bringhen, Sara, Maffei, Ilaria, Iannaccone, Andrea, Crea, Teresa, Ravera, Agnese, Astarita, Anna, Vallelonga, Fabrizio, Salvini, Marco, Gay, Francesca, Veglio, Franco, Milan, Alberto
Yayımlandı Cancers (Basel) (2019)

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE

Yazar: M Mateos, X Leleu, E Zamagni, M Delforge, S Bringhen, A Broijl, J de la Rubia, A Shaw, A Brescianini, S Gonzalez-McQuire, S Patel, P Moreau
Baskı/Yayın Bilgisi 2022-04-01

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1

Yazar: Bringhen, Sara, Voorhees, Peter M., Plesner, Torben, Mellqvist, Ulf‐Henrik, Reeves, Brandi, Sonneveld, Pieter, Byrne, Catriona, Nordström, Eva, Harmenberg, Johan, Obermüller, Jakob, Richardson, Paul G.
Yayımlandı Br J Haematol (2021)

Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

Yazar: Mian, Hira, Grant, Shakira J., Engelhardt, Monika, Pawlyn, Charlotte, Bringhen, Sara, Zweegman, Sonja, Stege, Claudia A.M., Rosko, Ashley E., von Lilienfeld-Toal, Marie, Wildes, Tanya M.
Yayımlandı J Geriatr Oncol (2020)

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

Yazar: Caltagirone, Simona, Ruggeri, Marina, Aschero, Simona, Gilestro, Milena, Oddolo, Daniela, Gay, Francesca, Bringhen, Sara, Musolino, Caterina, Baldini, Luca, Musto, Pellegrino, Petrucci, Maria T., Gaidano, Gianluca, Passera, Roberto, Bruno, Benedetto, Palumbo, Antonio, Boccadoro, Mario, Omedè, Paola
Baskı/Yayın Bilgisi 2014

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction

Yazar: Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Vallelonga, Fabrizio, Covella, Michele, Catarinella, Cinzia, Cesareo, Marco, Bruno, Giulia, Leone, Dario, Giordana, Carlo, Cetani, Giusy, Salvini, Marco, Gay, Francesca, Bringhen, Sara, Rabbia, Franco, Veglio, Franco, Milan, Alberto
Yayımlandı Cancers (Basel) (2021)

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients

Yazar: Mingrone, Giulia, Astarita, Anna, Airale, Lorenzo, Maffei, Ilaria, Cesareo, Marco, Crea, Teresa, Bruno, Giulia, Leone, Dario, Avenatti, Eleonora, Catarinella, Cinzia, Salvini, Marco, Cetani, Giusy, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Vallelonga, Fabrizio, Milan, Alberto
Yayımlandı Front Cardiovasc Med (2021)

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

Yazar: Palumbo, Antonio, Larocca, Alessandra, Genuardi, Mariella, Kotwica, Katarzyna, Gay, Francesca, Rossi, Davide, Benevolo, Giulia, Magarotto, Valeria, Cavallo, Federica, Bringhen, Sara, Rus, Cecilia, Masini, Luciano, Iacobelli, Massimo, Gaidano, Gianluca, Mitsiades, Constantine, Anderson, Kenneth, Boccadoro, Mario, Richardson, Paul
Baskı/Yayın Bilgisi 2010

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

Yazar: Dimopoulos, Meletios, Bringhen, Sara, Anttila, Pekka, Capra, Marcelo, Cavo, Michele, Cole, Craig, Gasparetto, Cristina, Hungria, Vania, Jenner, Matthew, Vorobyev, Vladimir, Ruiz, Eduardo Yanez, Yin, Jian Y., Saleem, Rao, Hellet, Maeva, Macé, Sandrine, Paiva, Bruno, Vij, Ravi
Yayımlandı Blood (2021)

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

Yazar: Schjesvold, Fredrik, Richardson, Paul G., Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L., Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
Yayımlandı Haematologica (2021)

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Yazar: Facon, Thierry, Niesvizky, Ruben, Mateos, Maria-Victoria, Siegel, David, Rosenbaum, Cara, Bringhen, Sara, Weisel, Katja, Ho, P. Joy, Ludwig, Heinz, Kumar, Shaji, Wang, Kenneth, Obreja, Mihaela, Yang, Zhao, Klippel, Zandra, Mezzi, Khalid, Goldrick, Amanda, Tekle, Christina, Dimopoulos, Meletios A.
Yayımlandı Blood Adv (2020)

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-do...

Yazar: Mateos, María-Victoria, Bringhen, Sara, Richardson, Paul G., Lahuerta, Juan Jose, Larocca, Alessandra, Oriol, Albert, Boccadoro, Mario, García-Sanz, Ramón, Di Raimondo, Francesco, Esseltine, Dixie-Lee, van de Velde, Helgi, Desai, Avinash, Londhe, Anil, San Miguel, Jesús F., Palumbo, Antonio
Baskı/Yayın Bilgisi 2014